181 related articles for article (PubMed ID: 24077328)
1. Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.
Mathew G; Mitchell A; Down JM; Jacobs LA; Hamdy FC; Eaton C; Rosario DJ; Cross SS; Winder SJ
Sci Rep; 2013 Sep; 3():2792. PubMed ID: 24077328
[TBL] [Abstract][Full Text] [Related]
2. γ-Secretase Dependent Nuclear Targeting of Dystroglycan.
Leocadio D; Mitchell A; Winder SJ
J Cell Biochem; 2016 Sep; 117(9):2149-57. PubMed ID: 26990187
[TBL] [Abstract][Full Text] [Related]
3. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
4. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
5. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.
Sgambato A; De Paola B; Migaldi M; Di Salvatore M; Rettino A; Rossi G; Faraglia B; Boninsegna A; Maiorana A; Cittadini A
J Cell Physiol; 2007 Nov; 213(2):528-39. PubMed ID: 17516554
[TBL] [Abstract][Full Text] [Related]
6. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
7. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
[TBL] [Abstract][Full Text] [Related]
8. The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.
Richmond O; Ghotbaddini M; Allen C; Walker A; Zahir S; Powell JB
PLoS One; 2014; 9(4):e95058. PubMed ID: 24755659
[TBL] [Abstract][Full Text] [Related]
9. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
[TBL] [Abstract][Full Text] [Related]
10. Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.
Eich ML; Chandrashekar DS; Rodriguez Pen A MDC; Robinson AD; Siddiqui J; Daignault-Newton S; Chakravarthi BVSK; Kunju LP; Netto GJ; Varambally S
Prostate; 2019 Oct; 79(14):1629-1639. PubMed ID: 31376196
[TBL] [Abstract][Full Text] [Related]
11. ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C; Hsieh CL; Omwancha J; Zheng Z; Chen SY; Baert JL; Shemshedini L
Mol Endocrinol; 2007 Aug; 21(8):1835-46. PubMed ID: 17505060
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
[TBL] [Abstract][Full Text] [Related]
13. Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Cinar B; Al-Mathkour MM; Khan SA; Moreno CS
J Biol Chem; 2020 Jun; 295(25):8550-8559. PubMed ID: 32376689
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
15. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
[TBL] [Abstract][Full Text] [Related]
16. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.
Jones J; Wang H; Zhou J; Hardy S; Turner T; Austin D; He Q; Wells A; Grizzle WE; Yates C
Am J Pathol; 2012 Nov; 181(5):1836-46. PubMed ID: 22974583
[TBL] [Abstract][Full Text] [Related]
18. Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
Mitchell A; Mathew G; Jiang T; Hamdy FC; Cross SS; Eaton C; Winder SJ
Prostate; 2013 Mar; 73(4):398-408. PubMed ID: 22996647
[TBL] [Abstract][Full Text] [Related]
19. Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer.
Jiang X; Rieder S; Giese NA; Friess H; Michalski CW; Kleeff J
J Surg Res; 2011 Nov; 171(1):120-6. PubMed ID: 20338590
[TBL] [Abstract][Full Text] [Related]
20. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]